REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL Medication Singapore | Medicine SG

REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL is a medication in Singapore. The dosage in INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION form, is administered by the INTRAVENOUS route. The licence is held by CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED, approved on 1970-01-01, with the number SIN14972P. The forensic classification is Prescription Only, and ATC code is L04AB02.

Permalink: https://www.medicinesg.com/sg/meds/remsima-powder-for-concentrate-for-solution-for-infusion-100-mg-vial/

Licence number: SIN14972P
Product name: REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL
License holder: CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED
Approval date: 1970-01-01
Forensic classification: Prescription Only
ATC Code: L04AB02
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route of Administration: INTRAVENOUS
Manufacturer & Country of manufacturer:
- Mustafa Nevzat Ilac Sanayii A.S. – TURKEY
- CELLTRION Inc., Plant II (CLT2) – KOREA, REPUBLIC OF
Active ingredients & Strength:
- Infliximab – 100mg/vial